ZYQ-45744-01385

3 vaccinations 11 coded responses 38 check-ins 11 free-text entries 3 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 376 / TN
Registered: 2021-01-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-06
Registered in v-safe
2021-01-06
Dose 1 — Pfizer-BioNTech
2021-01-06
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Joint pains

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-15
Survey response — day 7, dose 1
MedDRA: Pre-existing disease — Feeling: Good · Headache, Joint pains, Nausea, Abdominal pain

Free text: I have MS and got my monthly Tysabri infusion yesterday, these are common side effects with that treatment.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-21
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-26
Dose 2 — Pfizer-BioNTech
2021-01-27
Survey response — days 1–6 daily, dose 2
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: worsening of existing MS symptoms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Nausea, Abdominal pain

Adult check-in
2021-01-29
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Multiple sclerosis — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Nausea · Be unable to work

Free text: Dizziness, I have MS so not sure if its that

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-02
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-02
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-27
Survey response — 3 months, dose 2
MedDRA: JC polyomavirus test positive, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: JC Virus positive, previously indeterminate · Healthcare visit (other): Monitoring with q4week labs for PML risk

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-27
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-23
Dose 3 — Pfizer-BioNTech
2021-11-23
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness

Adult check-in
2021-11-24
Survey response — days 1–6 daily, dose 3
MedDRA: Herpes zoster — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Shingles reactivation

MedDRA releases: 2024-11 · check-in free text available
2021-11-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-27
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-30
Survey response — day 7, dose 3
MedDRA: Dizziness — Feeling: Good

Free text: Dizziness

MedDRA releases: 2024-11 · check-in free text available
2021-12-07
Survey response — day 14, dose 3
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Good

Free text: Slight exacerbation in MS symptoms, but remain functional

MedDRA releases: 2024-11 · check-in free text available
2021-12-14
Survey response — day 21, dose 3
MedDRA: Neurological symptom — Feeling: Good

Free text: New MS symptoms

MedDRA releases: 2024-11 · check-in free text available
2021-12-21
Survey response — day 28, dose 3
MedDRA: Haemoperitoneum, Ovarian haemorrhage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Bleeding ovary with mild hemoperitoneum

MedDRA releases: 2024-11 · check-in free text available
2021-12-21
Report sent to call center — day 28, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-22
Call 2 — Left Voicemail
2021-12-28
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-04
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-22
Survey response — 3 months, dose 3
MedDRA: COVID-19, Full blood count abnormal, Lymphocytosis, Office visit — Feeling: Good · Be unable to work or attend school

Free text: Had Covid in January. CBC shows mild lymphocytosis one month later, following with PCP

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Survey response — 6 months, dose 3
MedDRA: Muscle atrophy, Muscular weakness, Pre-existing disease, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Have had MS for 7 years, new onset mild left thigh and calf atrophy and weakness. Awaiting appt with treating neurologist · Healthcare visit (other): 2g corticosteroid IV x 2

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-05-25
Call 1 — Left Voicemail
2022-05-25
Call 1 — Left Voicemail
2022-05-25
Call 1 — Left Voicemail
2022-11-25
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-06	Pfizer-BioNTech
2	2021-01-26	Pfizer-BioNTech
3	2021-11-23	Pfizer-BioNTech	No

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 7, dose 1

2021-01-15

Systemic reaction (other): I have MS and got my monthly Tysabri infusion yesterday, these are common side effects with that treatment.

Release 2 — days 1–6 daily, dose 2

2021-01-27

Systemic reaction (other): worsening of existing MS symptoms

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Dizziness, I have MS so not sure if its that

Release 8 — 3 months, dose 2

2021-04-27

Symptoms: JC Virus positive, previously indeterminate

Healthcare visit (other): Monitoring with q4week labs for PML risk

Release 10 — days 1–6 daily, dose 3

2021-11-24

Systemic reaction (other): Shingles reactivation

Release 10 — day 7, dose 3

2021-11-30

Systemic reaction (other): Dizziness

Release 10 — day 14, dose 3

2021-12-07

Symptoms: Slight exacerbation in MS symptoms, but remain functional

Release 10 — day 21, dose 3

2021-12-14

Symptoms: New MS symptoms

Release 10 — day 28, dose 3

2021-12-21

Symptoms: Bleeding ovary with mild hemoperitoneum

Release 11 — 3 months, dose 3

2022-02-22

Symptoms: Had Covid in January. CBC shows mild lymphocytosis one month later, following with PCP

Release 11 — 6 months, dose 3

2022-05-24

Symptoms: Have had MS for 7 years, new onset mild left thigh and calf atrophy and weakness. Awaiting appt with treating neurologist

Healthcare visit (other): 2g corticosteroid IV x 2

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Full blood count abnormal	·	·	✓
SD	Haemoperitoneum	·	·	✓
SD	JC polyomavirus test positive	✓	✓	✓
SD	Lymphocytosis	·	·	✓
SD	Multiple sclerosis	·	·	✓
SD	Muscle atrophy	·	·	✓
SD	Muscular weakness	·	·	✓
SD	Neurological symptom	·	·	✓
SD	Office visit	·	·	✓
SD	Ovarian haemorrhage	·	·	✓
SD	Pre-existing disease	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Herpes zoster	·	·	✓
SRO	Multiple sclerosis	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release